Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wallis

Showing results (241-250 of 476) with videos related to

Pageof 48
Sort By:
International Journal of Antimicrobial Agents|February 23, 2018
Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial programA Stewart, J A Roberts, S C Wallis, et al.
Applied and Environmental Microbiology|September 1, 1976
Virus and bacteria removal from wastewater by land treatmentR G Gilbert, C P Gerba, R C Rice, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
LC-MS profiling of <i>prmt-1</i> and <i>prmt-5</i> knockout <i>C. elegans</i> reveals PRMT-1 substrates and global proteome remodelingAli Basirattalab, Dylan C Wallis, Nicolas G Hartel, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2022
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical IsolatesNatalija Karabasevic, Jason A Roberts, Luke Stronach, et al.
Analytical and Bioanalytical Chemistry|November 17, 2019
A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic studySuzanne L Parker, Saurabh Pandey, Fekade B Sime, et al.
The Journal of Small Animal Practice|July 15, 2018
A longitudinal assessment of periodontal health status in 53 Labrador retrieversC Wallis, K V Patel, M Marshall, et al.
Journal of Vascular Surgery|October 24, 1998
Peripheral aneurysms and arteriomegaly: is there a familial pattern?P F Lawrence, C Wallis, P B Dobrin, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2015
Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patientsJudith Bellapart, Jason Alexander Roberts, Vinesh Appadurai, et al.
American Journal of Obstetrics and Gynecology|December 15, 1973
Herpes genitalis treated by photodynamic inactivation of virusR H Kaufman, H L Gardner, D Brown, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2025
Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjectsMaría Patricia Hernández-Mitre, Steven C Wallis, Jeffery S Loutit, et al.
Pageof 48

Showing results (241-250 of 476) with videos related to

Sort By:
Pageof 48
International Journal of Antimicrobial Agents|February 23, 2018
Evidence of clinical response and stability of Ceftolozane/Tazobactam used to treat a carbapenem-resistant Pseudomonas Aeruginosa lung abscess on an outpatient antimicrobial programA Stewart, J A Roberts, S C Wallis, et al.
Applied and Environmental Microbiology|September 1, 1976
Virus and bacteria removal from wastewater by land treatmentR G Gilbert, C P Gerba, R C Rice, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
LC-MS profiling of <i>prmt-1</i> and <i>prmt-5</i> knockout <i>C. elegans</i> reveals PRMT-1 substrates and global proteome remodelingAli Basirattalab, Dylan C Wallis, Nicolas G Hartel, et al.
Antimicrobial Agents and Chemotherapy|April 7, 2022
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical IsolatesNatalija Karabasevic, Jason A Roberts, Luke Stronach, et al.
Analytical and Bioanalytical Chemistry|November 17, 2019
A validated LC-MSMS method for the simultaneous quantification of meropenem and vaborbactam in human plasma and renal replacement therapy effluent and its application to a pharmacokinetic studySuzanne L Parker, Saurabh Pandey, Fekade B Sime, et al.
The Journal of Small Animal Practice|July 15, 2018
A longitudinal assessment of periodontal health status in 53 Labrador retrieversC Wallis, K V Patel, M Marshall, et al.
Journal of Vascular Surgery|October 24, 1998
Peripheral aneurysms and arteriomegaly: is there a familial pattern?P F Lawrence, C Wallis, P B Dobrin, et al.
Clinical Chemistry and Laboratory Medicine|September 10, 2015
Pharmacokinetics of a novel dosing regimen of oral melatonin in critically ill patientsJudith Bellapart, Jason Alexander Roberts, Vinesh Appadurai, et al.
American Journal of Obstetrics and Gynecology|December 15, 1973
Herpes genitalis treated by photodynamic inactivation of virusR H Kaufman, H L Gardner, D Brown, et al.
Antimicrobial Agents and Chemotherapy|September 15, 2025
Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjectsMaría Patricia Hernández-Mitre, Steven C Wallis, Jeffery S Loutit, et al.
Pageof 48